Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1219-2026

LSL Healthcare, Central Line Dressing Kit Recall

LSL Healthcare, Central Line Dressing Kit, Model/Catalog Number: 2519CP, medical procedure convenience kit

FDA recall Class II

Ongoing

FDA lists this Class II recall for LSL Healthcare, Central Line Dressing Kit. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1219-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Dec 22, 2025
FDA report date
Feb 4, 2026
Quantity in commerce
1400 kits
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

LSL Healthcare, Central Line Dressing Kit, Model/Catalog Number: 2519CP, medical procedure convenience kit

Affected model & UDI checker

Search the exact identifiers published for Z-1219-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
2519CPLSL Healthcare, Central Line Dressing KitCheck source noticeNot specified
Not specifiedLSL Healthcare, Central Line Dressing KitCheck source notice00661392048157
FDA code information

Lot Code: Model No. 2519CP; UDI-DI 00661392048157; Lot# 5G3119; Expiration Date 7/31/26 GTIN: (01)00661392048157(10)5G3119(17)260731

View the original FDA recall notice

Why was this product recalled?

BD ChloraPrep Triple Swabsticks, a component within the kits, exhibit an open seal on the packaging of the applicators.

What actions did LSL Healthcare Inc. take?

LSL issued issued an URGENT: Kit Component Recall notice to its sole consignee on 12/22/2025 via email. The notice explained the issue and requested the following actions: "1. Immediately stop using the affected kits in your facility. 2. Inspect all inventory locations within your facility and destroy all affected kits according to your facility's disposal process. If destruction is not feasible immediately, the products should be quarantined until proper disposal can occur. If disposal is not possible, please request a Return Merchandise Authorization (RMA) to return these kits as indicated below. 3. This recall should be executed at the distributor, hospital, and user levels. Identify all customers within your distribution network who may have purchased the affected products listed in this notification. Provide a copy of the attached customer letter to all of these customers to inform them of the recall on behalf of BD & LSL. 4. Complete the attached Response Form and return it to the LSL contact provided on the form if you have any of the affected products in stock. This will help LSL acknowledge your receipt of this notification. Please indicate the quantity of affected products identified in your facility and confirm whether this inventory was destroyed or returned. 5. If you require assistance with this process, please contact your LSL representative or reach out to LSL using the contact information provided below. LSL Industries LLS, dba LSL Healthcare 6200 W. Howard Street Nile, IL, 60714 (888) 225-5575 | lslorderinquiries@lslhealthcare.com" LSL will provide credit for any destroyed products from the specific lot numbers mentioned above to customers who purchased the affected items directly from LSL. This will occur upon receipt of the completed Response Form.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology